Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sirka Nitschmann

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Innere Medizin (Heidelberg, Germany)|September 14, 2023
[Does alcohol minimum unit pricing lead to a reduction in deaths and hospitalizations?]Monika Rau, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|June 30, 2025
[Monoclonal antibodies in patients with chronic inflammatory bowel diseases]Elisabeth Schnoy, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|August 25, 2025
[Extended secondary prevention in cancer-associated venous thromboembolism: API-CAT establishes clarity]Florian Langer, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|October 9, 2023
[Bariatric surgery in nonalcoholic steatohepatitis]Elke Roeb, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|March 14, 2024
[Low-dose amitriptyline for irritable bowel syndrome]Jost Langhorst, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|May 6, 2024
[Treatment of atrial fibrillation in frail patients]Matthias Leschke, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|January 12, 2024
[Does a higher dose of oral semaglutide treatment make sense?]Stephan Martin, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|July 10, 2025
[Tirzepatide for heart failure with preserved ejection fraction (HFpEF) and obesity-the cardiometabolic turnaround?]Stefan Störk, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|September 26, 2024
[Olezarsen for the treatment of hypertriglyceridemia and familial chylomicronemia syndrome]Holger Leitolf, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|August 4, 2022
[Anifrolumab in the treatment of systemic lupus erythematosus]Martin Aringer, Sirka Nitschmann
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Innere Medizin (Heidelberg, Germany)|September 14, 2023
[Does alcohol minimum unit pricing lead to a reduction in deaths and hospitalizations?]Monika Rau, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|June 30, 2025
[Monoclonal antibodies in patients with chronic inflammatory bowel diseases]Elisabeth Schnoy, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|August 25, 2025
[Extended secondary prevention in cancer-associated venous thromboembolism: API-CAT establishes clarity]Florian Langer, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|October 9, 2023
[Bariatric surgery in nonalcoholic steatohepatitis]Elke Roeb, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|March 14, 2024
[Low-dose amitriptyline for irritable bowel syndrome]Jost Langhorst, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|May 6, 2024
[Treatment of atrial fibrillation in frail patients]Matthias Leschke, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|January 12, 2024
[Does a higher dose of oral semaglutide treatment make sense?]Stephan Martin, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|July 10, 2025
[Tirzepatide for heart failure with preserved ejection fraction (HFpEF) and obesity-the cardiometabolic turnaround?]Stefan Störk, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|September 26, 2024
[Olezarsen for the treatment of hypertriglyceridemia and familial chylomicronemia syndrome]Holger Leitolf, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|August 4, 2022
[Anifrolumab in the treatment of systemic lupus erythematosus]Martin Aringer, Sirka Nitschmann
Pageof 6